|
|
|
2020 Abstract Information will be posted in February 2020. Please check back for updates.
Call for Abstracts opens |
February 2020 |
Online registration opens |
February 2020 |
Abstract submission deadline |
tbc |
Notice of Abstract adjudication |
tbc |
Deadline for presenting authors to register |
tbc |
Early registration deadline |
tbc |
Hotel booking deadline (based on availability) |
tbc |
Abstract Format
Please indicate your preference for oral or poster presentation in the online submission. Due to the limited number of oral presentations available in the SHSA program, meritorious abstracts not assigned to oral presentation, will be accepted for posters. Abstracts submitted by commercial industry representatives may only be considered for poster presentation. Indicate in the online submission system if you do not wish to accept a poster presentation in this instance, in which case your abstract may be declined should it not be accepted for oral presentation. For eligibility of travel grant and scholarships, please review the SHSA Travel Grant link.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on TBC. This submission deadline will not be extended. Notifications will be sent to the accepted abstract submitters and accepted presenters.
Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu in the online submission system. Abstracts submitted by industry representatives may only be considered for poster presentation.
Submitting authors and/or presenters may modify their submission(s) until the closing date of TBC.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Topics will be available in a drop-down menu on the online submission site. Categories will be used for reviewing and indexing purposes.
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by TBC in order for the abstract to be included in the program.
Please indicate your preference for oral or poster presentation in the online submission. Due to the limited number of oral presentations available in the SHSA program, meritorious abstracts not assigned to oral presentation, will be accepted for posters. Abstracts submitted by commercial industry representatives may only be considered for poster presentation. Indicate in the online submission system if you do not wish to accept a poster presentation in this instance, in which case your abstract may be declined should it not be accepted for oral presentation. For eligibility of travel grant and scholarships, please review the SHSA Travel Grant link.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on TBC. This submission deadline will not be extended. Notifications will be sent to the accepted abstract submitters and accepted presenters.
Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu in the online submission system. Abstracts submitted by industry representatives may only be considered for poster presentation.
Submitting authors and/or presenters may modify their submission(s) until the closing date of TBC.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Topics will be available in a drop-down menu on the online submission site. Categories will be used for reviewing and indexing purposes.
- Epidemiology and Health Services Research
- Clinical Research
- Comorbidities and complications
- Basic & Translational research
- Therapy including surgical, medical, and complementary
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by TBC in order for the abstract to be included in the program.
Abstract Guidelines
Abstracts selected for presentations in the 5th Annual SHSA will be reproduced exactly as submitted and substitutions and changes will not be permitted after the closing date. Be sure to proofread your abstract very carefully before submitting.
- Prepare your abstract in MS Word
- Do not use presentation software, such as PowerPoint
- Limit your abstract (body) to no more than 300 words
- Refer to generic names, rather than brand names
- It is suggested, other than case presentations, to separate your abstract into three (3) paragraphs:
- Introduction
- Methods, Results
- Conclusions
- Include learning objectives and a takeaway message.
Abstracts selected for presentations in the 5th Annual SHSA will be reproduced exactly as submitted and substitutions and changes will not be permitted after the closing date. Be sure to proofread your abstract very carefully before submitting.